-
Trofinetide, sold
under the
brand name Daybue, is a
medication used for the
treatment of Rett syndrome. It is
taken by mouth. The most
common adverse...
- for example,
rebreathing masks may be used
while the
child is awake.
Trofinetide, sold
under the
brand name Daybue, is a
medication used for the treatment...
- some
evidence that
phenytoin may be more
effective than a beta-blocker.
Trofinetide, sold
under the
brand name Daybue, is a
medication used for the treatment...
- Genzyme's small-molecule
compound library. In 2023, the FDA
approved trofinetide (marketed as Daybue) for use in Rett syndrome.
Acadia started in 1993...
-
ursodoxicoltaurine N07XX21 Ep****rsen N07XX22
Tofersen N07XX23
Troriluzole N07XX24
Trofinetide N07XX25
Omaveloxolone N07XX59 Dextromethorphan,
combinations "ATC (Anatomical...
- IGF-2)
Others Binding proteins:
IGFBP (1, 2, 3, 4, 5, 6, 7)
Cleavage products/derivatives with
unknown target:
Glypromate (GPE, (1-3)IGF-1)
Trofinetide...
- IGF-2)
Others Binding proteins:
IGFBP (1, 2, 3, 4, 5, 6, 7)
Cleavage products/derivatives with
unknown target:
Glypromate (GPE, (1-3)IGF-1)
Trofinetide...
- IGF-2)
Others Binding proteins:
IGFBP (1, 2, 3, 4, 5, 6, 7)
Cleavage products/derivatives with
unknown target:
Glypromate (GPE, (1-3)IGF-1)
Trofinetide...
- IGF-2)
Others Binding proteins:
IGFBP (1, 2, 3, 4, 5, 6, 7)
Cleavage products/derivatives with
unknown target:
Glypromate (GPE, (1-3)IGF-1)
Trofinetide...
- IGF-2)
Others Binding proteins:
IGFBP (1, 2, 3, 4, 5, 6, 7)
Cleavage products/derivatives with
unknown target:
Glypromate (GPE, (1-3)IGF-1)
Trofinetide...
